Cempra, Inc. Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 4,166,167 shares of common stock of Cempra, Inc. The net proceeds to Cempra were approximately $93.7…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Biogen Inc. $6 Billion Senior Notes Offering
Davis Polk advised the underwriters, in connection with the SEC-registered offering by Biogen Inc. of $1.5 billion principal amount of 2.900% senior notes due 2020, $1.0 billion principal…
Davis Polk Advises SS&C on Its Acquisition of Primatics Financial
Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its approximately $122 million acquisition of Primatics Financial from The Carlyle Group. The acquisition is…